FREEMEDSITE MRCS ACADEMY • ARTICLE 17 • PAPER 1 PHARMACOLOGY AND MICROBIOLOGY

Surgical Pharmacology and Microbiology Made Easy for MRCS Part A

Understand antibiotics, resistance, perioperative prophylaxis, common surgical organisms, culture interpretation and high-yield drug mechanisms, then practise 40 original five-option clinical SBAs.

12 teaching modules52 saved revision topics40 fully explained SBAs3 original diagrams

FreeMedSite • Updated October 2026 • Educational questions written independently; not confidential exam recalls

How to use this article

First learn mechanisms, typical adverse effects and clinically important bacterial targets. Then complete the 52-topic revision checklist and tackle the 40-question practice assessment. The questions provide feedback, detailed explanations for every answer option, exam pearls, traps and answered viva extensions.

Recall-informed but original: Uploaded MRCS project recalls informed topic selection, but recalled stems and unverified answer keys have not been republished or treated as verified. Where treatment decisions are discussed, check current local antimicrobial guidance.

Clinical safety: Drug regimens, doses, resistance patterns and antibiotic choices vary by patient, organism and region. This educational article is not a treatment protocol.

On this page

Core pharmacology: receptors, kinetics and doseAntibiotic pharmacodynamics: time and concentrationBeta-lactams and glycopeptides: cell-wall targetsProtein-synthesis inhibitors and adverse effectsOther antimicrobial mechanisms and examiner trapsEssential surgical microbiology: Gram stain and identificationRecognising likely pathogens by surgical syndromeAnaerobes, toxins and antibiotic-associated diarrhoeaCultures, antibiograms, susceptibility and source controlSurgical antibiotic prophylaxis versus treatmentAntimicrobial stewardship, resistance and AWaRePerioperative pharmacology: analgesia, anaesthesia and emergencies52-topic revision checklist40 original five-option SBAsFAQsSources and related MRCS articles

1. Core pharmacology: receptors, kinetics and dose

Pharmacodynamics explains what a drug does to the body: receptor binding, agonism, antagonism and dose-response. Pharmacokinetics explains absorption, distribution, metabolism and excretion (ADME). A loading dose depends mainly on volume of distribution and target concentration; maintenance dosing depends on clearance. Bioavailability changes systemic exposure following non-intravenous administration.

Clinical application

For a septic postoperative patient with impaired renal function, choose an appropriate loading strategy when indicated, then review maintenance intervals against clearance and measured concentrations for drugs requiring therapeutic monitoring.

MRCS exam pearl

Loading dose: volume of distribution. Maintenance rate: clearance. Half-life is influenced by both.

2. Antibiotic pharmacodynamics: time and concentration

Beta-lactam efficacy correlates mainly with the time that free drug concentrations remain above the pathogen minimum inhibitory concentration (fT>MIC). Aminoglycosides are classically concentration-dependent with a post-antibiotic effect. Both require appropriate patient-specific dosing, source control and microbiological reassessment.

Clinical application

Do not assume that extending the duration of every antibiotic is helpful. Match dose, interval and duration to the organism, infection focus, renal function and current stewardship guidance.

MRCS exam pearl

Time-dependent beta-lactams versus concentration-dependent aminoglycosides is a frequent MRCS distinction.

3. Beta-lactams and glycopeptides: cell-wall targets

Penicillins, cephalosporins and carbapenems contain a beta-lactam ring and inhibit bacterial cell-wall cross-linking by binding penicillin-binding proteins (transpeptidases). Beta-lactamases can hydrolyse susceptible agents; some organisms have altered PBPs. Vancomycin blocks peptidoglycan formation by binding D-Ala-D-Ala termini and is primarily active against Gram-positive organisms. It is not useful for infections caused exclusively by Gram-negative bacilli.

Clinical application

For a suspected prosthetic-associated infection, identify likely pathogens and take appropriate microbiology specimens; avoid treating every Gram-positive isolate as vancomycin-sensitive without evidence.

MRCS exam pearl

MRSA frequently expresses PBP2a (mecA/mecC mechanism); vancomycin does not bind PBPs like beta-lactams.

Figure 1. Different antibiotic classes attack different bacterial structures; these are simplified mechanisms, not individual prescribing instructions.

4. Protein-synthesis inhibitors and adverse effects

Aminoglycosides bind the 30S ribosomal subunit and can cause renal and vestibular/auditory toxicity. Tetracyclines inhibit 30S; macrolides and clindamycin target 50S. Linezolid also acts on 50S and can cause myelosuppression with longer exposure. Inhibiting ribosomal protein synthesis does not imply an identical spectrum for every agent.

Clinical application

A patient prescribed an aminoglycoside needs attention to renal function, concomitant nephrotoxic drugs and appropriately indicated drug-level monitoring.

MRCS exam pearl

Aminoglycosides: 30S with nephrotoxicity/ototoxicity; macrolides and clindamycin: 50S.

5. Other antimicrobial mechanisms and examiner traps

Metronidazole forms DNA-damaging metabolites in susceptible anaerobic organisms. Fluoroquinolones impair DNA gyrase/topoisomerase and are associated with tendon and other potentially serious adverse effects. Rifampicin inhibits bacterial DNA-dependent RNA polymerase; rapid resistance can develop with inappropriate monotherapy. Trimethoprim and sulfonamides inhibit sequential steps in bacterial folate synthesis.

Clinical application

A clinician considering a fluoroquinolone in a patient at high tendon-risk should consult current restrictions, safer alternatives and local guidelines instead of treating it as a routine broad-spectrum default.

MRCS exam pearl

Metronidazole = anaerobic DNA damage; fluoroquinolones = DNA topoisomerases; rifampicin = RNA polymerase.

6. Essential surgical microbiology: Gram stain and identification

Gram-positive bacteria retain crystal violet due to their thick peptidoglycan layer. Gram-negative organisms have an outer membrane with lipopolysaccharide. Staphylococci are catalase-positive; S. aureus is coagulase-positive, whereas S. epidermidis is coagulase-negative. Laboratory identification, susceptibility tests and clinical relevance must be interpreted together.

Clinical application

A coagulase-negative staphylococcus isolated from a single superficial swab may be a contaminant; multiple concordant deep specimens from an implant procedure are much more persuasive for genuine infection.

MRCS exam pearl

Gram status, catalase and coagulase are identification clues, not substitutes for clinical assessment.

7. Recognising likely pathogens by surgical syndrome

S. aureus is an important cause of skin, deep musculoskeletal and postoperative infection. S. epidermidis and other coagulase-negative staphylococci can adhere to implanted devices and form biofilm. S. pyogenes may cause rapidly progressive soft-tissue infection. Anaerobes, including the Bacteroides fragilis group, are relevant to intra-abdominal contamination. Pseudomonas aeruginosa is a non-fermenting Gram-negative bacillus seen in selected healthcare-associated or moist-environment infections.

Clinical application

Rather than memorising a single antibiotic for every wound, first establish the likely source, depth, host factors, local resistance and whether urgent debridement or drainage is required.

MRCS exam pearl

Biofilm-associated implant infection is clinically distinct from uncomplicated superficial cellulitis.

8. Anaerobes, toxins and antibiotic-associated diarrhoea

Clostridium perfringens can produce alpha toxin and cause clostridial myonecrosis (gas gangrene), a surgical emergency requiring urgent debridement plus antimicrobials. Toxigenic Clostridioides difficile may cause antibiotic-associated colitis. Positive molecular detection without compatible symptoms can represent colonisation; testing and treatment depend on current guidance.

Clinical application

In suspected necrotising soft-tissue infection, urgently arrange surgical assessment and resuscitation; antibiotic selection is important but cannot replace operative source control.

MRCS exam pearl

Gas in tissue is not universally clostridial, but rapidly progressive myonecrosis must be treated as an emergency.

9. Cultures, antibiograms, susceptibility and source control

Before antibiotics when safe, obtain cultures from appropriate sites; however do not delay lifesaving treatment in unstable sepsis. In deep or implant-associated infections, intraoperative deep tissue samples are generally more informative than a superficial sinus swab. Minimum inhibitory concentration (MIC) is an in-vitro activity measure; organism-specific susceptibility breakpoints and achievable exposure are also needed. An abscess or devitalised tissue often requires drainage or debridement.

Clinical application

When a culture report names an organism, correlate specimen quality and number, contamination risk, sensitivity pattern and clinical response before narrowing therapy.

MRCS exam pearl

Microbiological sampling and drainage are different parts of source control; neither replaces the other.

Figure 3. Culture quality, patient severity and source control guide antibiotics; all steps may proceed concurrently in emergencies.

10. Surgical antibiotic prophylaxis versus treatment

Prophylaxis aims to achieve adequate tissue drug exposure at incision when indicated for the procedure. Antibiotic choice, timing, redosing and duration follow operation-specific evidence and local policies. Re-dosing may be required in a very prolonged case or major blood loss, depending on the agent. CDC SSI prevention guidance recommends not continuing additional routine prophylactic doses after surgical closure for clean and clean-contaminated procedures, even with a drain; local protocols and specific procedures may have additional considerations.

Clinical application

A patient undergoing contaminated emergency laparotomy with established peritonitis requires therapeutic antibiotics and source control, not simply a prophylactic dose.

MRCS exam pearl

Do not confuse the single-dose prophylaxis principle with treatment of existing infection.

Figure 2. Choose and time prophylaxis by procedure and local policy; this simplified timeline does not specify a universal dose or administration interval.

11. Antimicrobial stewardship, resistance and AWaRe

Appropriate stewardship means giving antimicrobials only when indicated, choosing the narrowest suitable spectrum, adjusting to cultures, avoiding unnecessary duration and reviewing IV-to-oral switch when safe. WHO AWaRe groups antibiotics into Access, Watch and Reserve to promote more appropriate use. Resistance may involve enzymatic drug destruction, altered drug targets, reduced entry or efflux pumps.

Clinical application

A stable patient whose cultures identify a susceptible organism may benefit from de-escalation rather than continuation of a wider empirical regimen without reassessment.

MRCS exam pearl

Broad-spectrum treatment is a temporary clinical decision, not an automatic marker of better care.

12. Perioperative pharmacology: analgesia, anaesthesia and emergencies

Local anaesthetics block voltage-gated sodium channels. Systemic local-anaesthetic toxicity can cause seizures, arrhythmia and circulatory collapse; stop the injection, support resuscitation and follow specialist lipid-emulsion protocols. Opioids can depress respiration and may be reversed with naloxone. NSAIDs inhibit cyclo-oxygenase and may worsen renal perfusion in vulnerable patients. Unfractionated heparin potentiates antithrombin, while warfarin inhibits vitamin K epoxide reductase. Intramuscular adrenaline is first-line treatment for anaphylaxis according to resuscitation guidelines.

Clinical application

The MRCS distinction is mechanism and immediate risk recognition; real medication doses, anticoagulant reversal and allergy management require contemporaneous patient-specific protocols.

MRCS exam pearl

Recognise naloxone–opioids, lipid emulsion–local anaesthetic toxicity, and adrenaline–anaphylaxis.

52-topic interactive revision checklist

Tick a topic once you can explain its mechanism and recognise the clinical consequence. Article 17 saves the ticks in this browser without changing progress from any other lesson.

0 / 52 topics completed

Saved only on this browser/device. Clearing site data or using private mode may remove progress. No external account is needed.

Core pharmacology

Pharmacodynamics versus pharmacokineticsADME and bioavailabilityLoading versus maintenance dosesHalf-life and drug clearance

PK/PD

MIC and susceptibility breakpointsBeta-lactam time-dependent killingAminoglycoside concentration-dependent killingDrug-level monitoring indications

Cell-wall agents

Penicillin-binding proteins and beta-lactamsBeta-lactamase and target resistanceVancomycin D-Ala-D-Ala actionMRSA altered PBP2a

Ribosomal agents

Aminoglycoside 30S actionMacrolide 50S mechanismClindamycin and C difficile riskLinezolid and cytopenias

Other antibiotics

Metronidazole and anaerobesFluoroquinolones and tendon riskRifampicin and monotherapy resistanceTMP–SMX and folate synthesis

Lab diagnosis

Gram-positive versus Gram-negative structureCatalase and coagulase testsSusceptibility report interpretationSuperficial versus deep specimen quality

Key surgical pathogens

S aureus in surgical infectionsS epidermidis and biofilmGroup A Streptococcus and necrotising infectionB fragilis in intra-abdominal infectionPseudomonas in healthcare-associated infection

Toxins and clostridia

C perfringens myonecrosisC difficile associated colitisToxin versus colonisationUrgency of surgical source control

Perioperative prophylaxis

Appropriate prophylaxis indicationTiming relative to incisionRedosing for long proceduresDiscontinuation after closureTreatment of established infection

Stewardship

WHO Access Watch ReserveCulture-directed de-escalationIV-to-oral switch principlesAntibiotic duration reassessmentResistance mechanisms: beta-lactamases and efflux

Analgesia and local anaesthesia

Sodium-channel blockadeLocal-anaesthetic systemic toxicityOpioid adverse effects and naloxoneNSAIDs and renal effects

Other perioperative medications

Anaphylaxis first-line therapyHeparin–antithrombin mechanismWarfarin–vitamin K cycleMedication review in renal impairmentHeparin versus warfarin reversal principles

40 original MRCS Part A clinical single-best-answer questions

Each question has five options A–E and one best answer. Exactly eight of the 40 correct responses occur under each option letter. Every distractor is individually explained, followed by a pearl, examiner trap and answered viva extension.

Answers and question position save automatically in this browser.

0 / 40Marked

0Correct

N/AAccuracy

Question 1 of 40

Question 1 of 40 • Beta-lactam mechanism

Q01. A patient with a susceptible streptococcal wound infection receives flucloxacillin. Which bacterial process is directly inhibited by its beta-lactam ring?

A. Peptidoglycan cross-linking by PBPsB. DNA gyrase activityC. 30S translation initiationD. Folate synthesisE. RNA polymerase

View detailed explanation, examiner trap and viva

Correct answer: A. Peptidoglycan cross-linking by PBPs

Why correct: Beta-lactams bind transpeptidase PBPs and inhibit bacterial cell-wall cross-linking.

Why the other options are incorrect:

B. DNA gyrase activity: Fluoroquinolones interfere with topoisomerases, not beta-lactams.

C. 30S translation initiation: Aminoglycosides and tetracyclines act at 30S ribosomes.

D. Folate synthesis: Sulfonamides and trimethoprim inhibit folate pathway steps.

E. RNA polymerase: Rifampicin acts at bacterial RNA polymerase.

Exam pearl: Beta-lactams are cell-wall synthesis inhibitors.

Examiner trap: PBPs are enzymes, not ribosomes.

Viva extension — What is one bacterial beta-lactam resistance mechanism? Answer: Production of beta-lactamase or an altered PBP.

Question 2 of 40 • Vancomycin

Q02. A postoperative wound yields methicillin-resistant Staphylococcus aureus susceptible to vancomycin. What is the most accurate molecular target of vancomycin?

A. Topoisomerase IVB. D-Ala-D-Ala termini of cell-wall precursorsC. 50S ribosomeD. Penicillin-binding proteins directlyE. Folate reductase

View detailed explanation, examiner trap and viva

Correct answer: B. D-Ala-D-Ala termini of cell-wall precursors

Why correct: Glycopeptides bind peptidoglycan precursor termini and hinder cell-wall synthesis in susceptible Gram-positive bacteria.

Why the other options are incorrect:

A. Topoisomerase IV: A fluoroquinolone-associated bacterial target.

C. 50S ribosome: Macrolides, clindamycin and linezolid act on this subunit.

D. Penicillin-binding proteins directly: Beta-lactams bind PBPs directly.

E. Folate reductase: Trimethoprim inhibits bacterial dihydrofolate reductase.

Exam pearl: Vancomycin is not a beta-lactam despite acting on cell-wall synthesis.

Examiner trap: Do not expect useful Gram-negative coverage from IV vancomycin alone.

Viva extension — Why may vancomycin be ineffective against Gram-negative bacteria? Answer: Their outer membrane generally prevents access to its target.

Question 3 of 40 • Aminoglycosides

Q03. An intensive-care patient treated with gentamicin develops rising creatinine and impaired hearing. Which drug property best explains the mechanism and toxicity?

A. 50S blockade without renal toxicityB. D-Ala-D-Ala bindingC. Irreversible 30S ribosomal binding with nephrotoxic and ototoxic potentialD. Folate synthesis inhibitionE. Cyclo-oxygenase inhibition

View detailed explanation, examiner trap and viva

Correct answer: C. Irreversible 30S ribosomal binding with nephrotoxic and ototoxic potential

Why correct: Aminoglycosides impair bacterial translation at 30S and can injure renal tubular and inner-ear cells.

Why the other options are incorrect:

A. 50S blockade without renal toxicity: Macrolides act at 50S and do not explain gentamicin toxicity.

B. D-Ala-D-Ala binding: Vancomycin has this target.

D. Folate synthesis inhibition: Applies to sulfonamide/trimethoprim combination.

E. Cyclo-oxygenase inhibition: NSAIDs block COX enzymes rather than microbial translation.

Exam pearl: Gentamicin: 30S, nephrotoxicity, ototoxicity.

Examiner trap: Do not overlook patient-specific renal monitoring.

Viva extension — What drug-level approach may be required? Answer: Regimen-specific therapeutic drug monitoring alongside renal assessment.

Question 4 of 40 • Tetracyclines

Q04. A student asks how doxycycline inhibits susceptible bacteria. Which action is most accurate?

A. 50S translocation inhibitionB. Direct cell-wall cross-link inhibitionC. DNA gyrase inhibitionD. Prevention of aminoacyl-tRNA binding at the 30S ribosomeE. Beta-lactamase inhibition

View detailed explanation, examiner trap and viva

Correct answer: D. Prevention of aminoacyl-tRNA binding at the 30S ribosome

Why correct: Tetracyclines bind the 30S subunit and prevent aminoacyl-tRNA entry to the acceptor site.

Why the other options are incorrect:

A. 50S translocation inhibition: Macrolides characteristically interfere with 50S translocation.

B. Direct cell-wall cross-link inhibition: Beta-lactams target PBPs.

C. DNA gyrase inhibition: Fluoroquinolones target bacterial DNA topoisomerases.

E. Beta-lactamase inhibition: Certain clavulanate-like agents inhibit some beta-lactamases.

Exam pearl: Doxycycline is a 30S inhibitor.

Examiner trap: A 30S target does not make tetracyclines aminoglycosides.

Viva extension — Name a classic safety restriction of tetracyclines. Answer: Avoid routine use in pregnancy and young children where alternatives are appropriate, subject to specific indications and modern guidance.

Question 5 of 40 • Macrolides

Q05. A patient taking clarithromycin develops a prolonged QT interval. Which ribosomal subunit is targeted by this antibiotic class?

A. 30S ribosomeB. Penicillin-binding proteinC. Bacterial DNA gyraseD. Cyclo-oxygenase-1E. 50S bacterial ribosomal subunit

View detailed explanation, examiner trap and viva

Correct answer: E. 50S bacterial ribosomal subunit

Why correct: Macrolides interfere with 50S-mediated protein synthesis and may prolong QT in susceptible patients.

Why the other options are incorrect:

A. 30S ribosome: Target of tetracyclines and aminoglycosides.

B. Penicillin-binding protein: Target of beta-lactams.

C. Bacterial DNA gyrase: Target of fluoroquinolones.

D. Cyclo-oxygenase-1: Host enzyme inhibited by NSAIDs, not macrolides.

Exam pearl: Macrolide = 50S; consider QT and interactions.

Examiner trap: Do not interpret QT prolongation as a class feature of every antibiotic.

Viva extension — Name another clinically relevant macrolide issue. Answer: Drug interactions, particularly with enzyme-inhibiting agents such as clarithromycin.

Question 6 of 40 • Clindamycin

Q06. Following prolonged antibiotic exposure, a patient develops new watery diarrhoea and abdominal pain. Which antimicrobial has a well-recognised association with Clostridioides difficile infection?

A. ClindamycinB. Topical mupirocinC. Single-dose perioperative antiseptic skin preparationD. Normal salineE. Intravenous paracetamol

View detailed explanation, examiner trap and viva

Correct answer: A. Clindamycin

Why correct: Clindamycin can disturb colonic microbiota and is strongly associated with antibiotic-associated C difficile disease.

Why the other options are incorrect:

B. Topical mupirocin: A topical anti-staphylococcal preparation is not the classic high-risk systemic exposure in this scenario.

C. Single-dose perioperative antiseptic skin preparation: Chlorhexidine preparation is not a systemic antibiotic course.

D. Normal saline: Contains no antibacterial drug.

E. Intravenous paracetamol: An analgesic, not a microbiome-disrupting antimicrobial.

Exam pearl: Clindamycin is a classic C difficile risk antibiotic.

Examiner trap: Other classes also cause C difficile; it is not exclusive to clindamycin.

Viva extension — How should a positive C difficile test be interpreted? Answer: Alongside compatible symptoms and the testing algorithm, not as proof of disease in an asymptomatic carrier.

Question 7 of 40 • Metronidazole

Q07. A patient with a perforated appendix has mixed aerobic and anaerobic intra-abdominal contamination. Which process best describes metronidazole activity against susceptible anaerobes?

A. Inhibition of bacterial transpeptidasesB. Formation of metabolites that damage microbial DNAC. 30S ribosomal blockadeD. Binding ergosterol in fungal membranesE. Inactivation of host cyclo-oxygenase

View detailed explanation, examiner trap and viva

Correct answer: B. Formation of metabolites that damage microbial DNA

Why correct: Under susceptible anaerobic conditions, metronidazole is reduced and forms reactive species that damage DNA.

Why the other options are incorrect:

A. Inhibition of bacterial transpeptidases: The beta-lactam mechanism.

C. 30S ribosomal blockade: Aminoglycoside/tetracycline mechanism.

D. Binding ergosterol in fungal membranes: Polyenes such as amphotericin bind ergosterol.

E. Inactivation of host cyclo-oxygenase: An NSAID action, not anaerobic bacterial killing.

Exam pearl: Metronidazole has important anaerobic activity.

Examiner trap: It does not reliably cover the aerobic Gram-negative pathogens of perforated appendicitis alone.

Viva extension — What else must intra-abdominal infection management address? Answer: Timely source control and appropriate coverage of relevant aerobic pathogens.

Question 8 of 40 • Fluoroquinolones

Q08. A 66-year-old patient develops Achilles tendon pain after starting a fluoroquinolone. Which bacterial enzyme group is inhibited by these antibiotics?

A. Penicillin-binding proteinsB. Dihydrofolate reductaseC. DNA gyrase and topoisomerase IVD. 50S peptidyl transferaseE. Beta-lactamase

View detailed explanation, examiner trap and viva

Correct answer: C. DNA gyrase and topoisomerase IV

Why correct: Fluoroquinolones impair bacterial DNA replication by inhibiting type II topoisomerases.

Why the other options are incorrect:

A. Penicillin-binding proteins: Beta-lactam targets.

B. Dihydrofolate reductase: Target of trimethoprim.

D. 50S peptidyl transferase: Affected by some protein-synthesis inhibitors, not fluoroquinolones.

E. Beta-lactamase: Drug-inactivating enzyme, not the fluoroquinolone target.

Exam pearl: Tendon symptoms warrant attention to fluoroquinolone serious adverse-effect warnings.

Examiner trap: Do not prescribe these agents reflexively when safer effective options exist.

Viva extension — What other problems are relevant to this class? Answer: Neurological, vascular and other rare but potentially severe reactions; consult current safety restrictions.

Question 9 of 40 • Co-trimoxazole

Q09. A urinary isolate is treated with trimethoprim-sulfamethoxazole. Why can the combination inhibit bacterial growth synergistically?

A. Two different PBPs are blockedB. Both bind 30S ribosomesC. DNA gyrase and RNA polymerase are blockedD. Sequential blockade of bacterial folate synthesisE. Microbial membranes are directly dissolved

View detailed explanation, examiner trap and viva

Correct answer: D. Sequential blockade of bacterial folate synthesis

Why correct: Sulfamethoxazole inhibits dihydropteroate synthase, and trimethoprim inhibits dihydrofolate reductase.

Why the other options are incorrect:

A. Two different PBPs are blocked: Neither is a beta-lactam PBP inhibitor.

B. Both bind 30S ribosomes: They act on folate, not ribosomes.

C. DNA gyrase and RNA polymerase are blocked: Targets of fluoroquinolones and rifampicin respectively.

E. Microbial membranes are directly dissolved: Not the principal co-trimoxazole mechanism.

Exam pearl: Trimethoprim and sulfonamides act sequentially.

Examiner trap: Do not assign antifolate mechanism to penicillin.

Viva extension — Which adverse laboratory change may trimethoprim produce? Answer: Hyperkalaemia, particularly with renal disease or interacting medicines.

Question 10 of 40 • Rifampicin

Q10. A patient with a staphylococcal prosthetic infection is considered for rifampicin-containing therapy after suitable surgical and microbiological evaluation. Why is rifampicin generally not used alone for such infection?

A. It is a beta-lactamase inhibitor onlyB. It has no activity against staphylococciC. It is entirely eliminated by the kidney without interactionsD. It is only an antifungal agentE. Resistance can emerge rapidly during monotherapy

View detailed explanation, examiner trap and viva

Correct answer: E. Resistance can emerge rapidly during monotherapy

Why correct: Rifampicin targets bacterial RNA polymerase and resistant mutants can be selected quickly if used as the only active agent.

Why the other options are incorrect:

A. It is a beta-lactamase inhibitor only: Rifampicin is an RNA polymerase inhibitor.

B. It has no activity against staphylococci: It can be active against susceptible staphylococci.

C. It is entirely eliminated by the kidney without interactions: It has significant drug-interaction potential.

D. It is only an antifungal agent: It is an antibacterial agent.

Exam pearl: Rifampicin resistance is selected quickly by monotherapy.

Examiner trap: Biofilm-related rifampicin regimens require specialist indications and companion therapy.

Viva extension — What is a major prescribing concern? Answer: Strong induction of several drug-metabolising enzymes and interactions.

Question 11 of 40 • Linezolid

Q11. A patient treated with prolonged linezolid for resistant Gram-positive infection develops thrombocytopenia. Which statement is most accurate?

A. Linezolid inhibits 50S bacterial protein synthesis and may cause myelosuppressionB. It binds D-Ala-D-AlaC. It directly destroys Gram-negative outer membranesD. It inhibits bacterial DNA gyraseE. It potentiates antithrombin

View detailed explanation, examiner trap and viva

Correct answer: A. Linezolid inhibits 50S bacterial protein synthesis and may cause myelosuppression

Why correct: Linezolid inhibits initiation of bacterial translation and can suppress bone marrow, especially with prolonged treatment.

Why the other options are incorrect:

B. It binds D-Ala-D-Ala: Vancomycin mechanism.

C. It directly destroys Gram-negative outer membranes: Not a characteristic linezolid action.

D. It inhibits bacterial DNA gyrase: Fluoroquinolone mechanism.

E. It potentiates antithrombin: Heparin effect, unrelated to linezolid.

Exam pearl: Monitor blood counts during prolonged linezolid therapy.

Examiner trap: A resistant Gram-positive indication is not an excuse to ignore toxicity monitoring.

Viva extension — What serotonergic risk can be relevant? Answer: Serotonin syndrome with certain interacting serotonergic medicines.

Question 12 of 40 • Daptomycin

Q12. A patient with a susceptible resistant Gram-positive bloodstream infection is considered for daptomycin. Which of these sites is unsuitable for daptomycin because pulmonary surfactant inhibits activity?

A. Selected bloodstream infectionsB. Alveolar pneumoniaC. Some right-sided endocarditisD. Certain skin and soft-tissue infectionsE. Selected deep Gram-positive infections with expert guidance

View detailed explanation, examiner trap and viva

Correct answer: B. Alveolar pneumonia

Why correct: Daptomycin membrane action is inactivated by lung surfactant; it is not appropriate for alveolar pneumonia.

Why the other options are incorrect:

A. Selected bloodstream infections: Daptomycin has roles in susceptible bacteremia.

C. Some right-sided endocarditis: It may be used in appropriate susceptible cases.

D. Certain skin and soft-tissue infections: Daptomycin has approved skin and soft-tissue indications.

E. Selected deep Gram-positive infections with expert guidance: It can be used for some other deep infections after specialist review.

Exam pearl: Daptomycin is not used for primary alveolar pneumonia.

Examiner trap: A drug active against MRSA is not automatically suitable for MRSA pneumonia.

Viva extension — What toxicity warrants monitoring? Answer: Myopathy/creatine kinase elevation.

Question 13 of 40 • MRSA resistance

Q13. A wound culture identifies S aureus resistant to methicillin and many standard beta-lactams. Which resistance mechanism is most characteristic?

A. Loss of all peptidoglycanB. Exclusive ribosomal 30S mutationC. mecA-associated altered penicillin-binding protein PBP2aD. Absence of catalase enzymeE. Production of endotoxin lipid A

View detailed explanation, examiner trap and viva

Correct answer: C. mecA-associated altered penicillin-binding protein PBP2a

Why correct: MRSA commonly expresses PBP2a, which has reduced affinity for many beta-lactams.

Why the other options are incorrect:

A. Loss of all peptidoglycan: Staphylococci still have a cell wall.

B. Exclusive ribosomal 30S mutation: Not the canonical mechanism of methicillin resistance.

D. Absence of catalase enzyme: S aureus is catalase positive.

E. Production of endotoxin lipid A: A Gram-negative outer membrane component, not S aureus.

Exam pearl: MRSA = altered PBP, not merely penicillinase.

Examiner trap: Some newer beta-lactams have anti-MRSA activity; never generalise across all beta-lactams.

Viva extension — Which laboratory test helps identify S aureus? Answer: Coagulase positivity.

Question 14 of 40 • Biofilm

Q14. Multiple deep cultures from an infected joint prosthesis grow S epidermidis. What bacterial property makes implant-related eradication difficult?

A. Obligate intracellular replicationB. Creation of fungal hyphaeC. Formation of motile sporesD. Formation of an adherent extracellular biofilmE. Dependence on host erythrocytes for growth

View detailed explanation, examiner trap and viva

Correct answer: D. Formation of an adherent extracellular biofilm

Why correct: Biofilm fosters microbial attachment to foreign material and can reduce antimicrobial and immune effectiveness.

Why the other options are incorrect:

A. Obligate intracellular replication: S epidermidis is not an obligate intracellular bacterium.

B. Creation of fungal hyphae: It is a bacterium, not a fungus.

C. Formation of motile spores: Staphylococci do not form spores.

E. Dependence on host erythrocytes for growth: Not its biological niche.

Exam pearl: S epidermidis can be genuine infection in concordant deep implant specimens.

Examiner trap: Do not dismiss every coagulase-negative isolate as contamination.

Viva extension — What besides antibiotics may be needed? Answer: A procedural source-control strategy, potentially including implant management, according to case-specific guidelines.

Question 15 of 40 • Group A Streptococcus

Q15. A patient develops rapidly spreading severe limb pain, systemic toxicity and necrotising soft-tissue infection. Which pathogen is a recognised cause of type II necrotising fasciitis?

A. S epidermidis onlyB. Candida albicans onlyC. Clostridioides difficileD. Bacillus subtilisE. Streptococcus pyogenes

View detailed explanation, examiner trap and viva

Correct answer: E. Streptococcus pyogenes

Why correct: Group A streptococcus can cause rapidly progressive necrotising fasciitis and toxin-mediated shock.

Why the other options are incorrect:

A. S epidermidis only: Primarily associated with device-related biofilm, not the canonical monomicrobial pattern.

B. Candida albicans only: A yeast, not the characteristic type II organism.

C. Clostridioides difficile: Predominantly causes antibiotic-associated colitis.

D. Bacillus subtilis: Not the usual cause of group A streptococcal necrotising fasciitis.

Exam pearl: Pain out of proportion can suggest necrotising infection.

Examiner trap: Imaging must not delay urgent surgical assessment when suspicion is high.

Viva extension — What is the cornerstone alongside resuscitation and antibiotics? Answer: Urgent operative debridement/source control.

Question 16 of 40 • Gas gangrene

Q16. A crush injury develops rapidly worsening pain, muscle necrosis and gas with systemic toxicity. Which toxin-producing organism classically causes clostridial myonecrosis?

A. Clostridium perfringensB. S epidermidisC. C difficileD. Moraxella catarrhalisE. Treponema pallidum

View detailed explanation, examiner trap and viva

Correct answer: A. Clostridium perfringens

Why correct: C perfringens produces phospholipase C alpha toxin and can cause fulminant clostridial myonecrosis.

Why the other options are incorrect:

B. S epidermidis: Implant biofilm organism, not classic gas gangrene agent.

C. C difficile: Usually causes antibiotic-associated colitis rather than clostridial myonecrosis.

D. Moraxella catarrhalis: A respiratory pathogen rather than this presentation.

E. Treponema pallidum: Causes syphilis, not clostridial gas gangrene.

Exam pearl: Clostridial myonecrosis requires urgent surgical treatment.

Examiner trap: Gas in soft tissue has more than one possible bacterial cause.

Viva extension — How does alpha toxin act? Answer: It is a phospholipase that damages cell membranes.

Question 17 of 40 • C difficile

Q17. A hospital inpatient has new-onset frequent unformed stools after antibiotic treatment. Which interpretation of a positive C difficile molecular assay is most appropriate?

A. Treat every asymptomatic positive resultB. Correlate the test with compatible symptoms and the local diagnostic algorithmC. Exclude CDI because the stool is wateryD. Assume blood cultures will always be positiveE. Presume the test proves a surgical anastomotic leak

View detailed explanation, examiner trap and viva

Correct answer: B. Correlate the test with compatible symptoms and the local diagnostic algorithm

Why correct: Molecular testing may detect toxigenic organisms in colonised patients; clinical features and testing criteria determine CDI diagnosis.

Why the other options are incorrect:

A. Treat every asymptomatic positive result: Colonisation does not necessarily equal infection.

C. Exclude CDI because the stool is watery: Watery diarrhoea is compatible with CDI.

D. Assume blood cultures will always be positive: CDI is usually a colonic infection, not bloodstream infection.

E. Presume the test proves a surgical anastomotic leak: The test cannot diagnose a mechanical leak.

Exam pearl: Do not equate colonisation with active C difficile disease.

Examiner trap: Recent laxative exposure and alternative diarrhoea causes also matter.

Viva extension — What infection-control intervention is important? Answer: Contact precautions and appropriate soap-and-water hygiene per local guidance.

Question 18 of 40 • Pseudomonas

Q18. A moist burn-wound culture grows an oxidase-positive non-fermenting Gram-negative rod, producing a blue-green pigment. Which organism is suggested?

A. S aureusB. B fragilisC. Pseudomonas aeruginosaD. S pyogenesE. C perfringens

View detailed explanation, examiner trap and viva

Correct answer: C. Pseudomonas aeruginosa

Why correct: Pseudomonas is an aerobic non-fermenting Gram-negative organism; oxidase positivity and pigments are classic clues.

Why the other options are incorrect:

A. S aureus: Gram-positive cocci, not a Gram-negative rod.

B. B fragilis: An anaerobic Gram-negative rod, not the classic aerobic oxidase-positive pigment producer.

D. S pyogenes: Gram-positive cocci in chains.

E. C perfringens: Gram-positive anaerobic spore-forming rod.

Exam pearl: Pseudomonas is a possible pathogen in selected burn and healthcare-associated infections.

Examiner trap: Culture alone does not prove it is the cause of every colonised wound.

Viva extension — How should antibiotic choice be made? Answer: Local susceptibility testing, site severity, patient factors and stewardship guidance.

Question 19 of 40 • Intra-abdominal anaerobes

Q19. A postoperative intra-abdominal abscess develops after colonic perforation. Which organism is a common clinically important anaerobic member of the colonic microbiota?

A. Staphylococcus epidermidisB. Neisseria meningitidisC. Legionella pneumophilaD. Bacteroides fragilis groupE. Bordetella pertussis

View detailed explanation, examiner trap and viva

Correct answer: D. Bacteroides fragilis group

Why correct: The B fragilis group contains obligate anaerobes associated with intra-abdominal infection after bowel contamination.

Why the other options are incorrect:

A. Staphylococcus epidermidis: A skin commensal and device organism, not the characteristic colonic anaerobe.

B. Neisseria meningitidis: A respiratory/meningeal pathogen.

C. Legionella pneumophila: Causes pneumonia, not characteristic colonic abscess infection.

E. Bordetella pertussis: Respiratory pathogen causing pertussis.

Exam pearl: Perforated-colon infection often involves mixed aerobic and anaerobic flora.

Examiner trap: Metronidazole alone does not cover all important aerobic Gram-negative organisms.

Viva extension — What is a management priority? Answer: Drainage or operative control of the contaminated focus.

Question 20 of 40 • Coagulase

Q20. Gram-positive cocci in clusters from a purulent surgical wound are catalase positive and coagulase positive. Which species is the best identification?

A. Staphylococcus epidermidisB. Streptococcus pyogenesC. Enterococcus faecalisD. Pseudomonas aeruginosaE. Staphylococcus aureus

View detailed explanation, examiner trap and viva

Correct answer: E. Staphylococcus aureus

Why correct: S aureus is typically catalase and coagulase positive.

Why the other options are incorrect:

A. Staphylococcus epidermidis: Usually coagulase negative.

B. Streptococcus pyogenes: Catalase-negative streptococci are typically in chains.

C. Enterococcus faecalis: Usually catalase negative and arranged in pairs/chains.

D. Pseudomonas aeruginosa: A Gram-negative rod rather than a cluster-forming Gram-positive coccus.

Exam pearl: S aureus = coagulase positive.

Examiner trap: A positive Gram stain does not replace susceptibility testing.

Viva extension — What feature is associated with MRSA? Answer: Expression of altered PBP2a.

Question 21 of 40 • Gram-positive stain

Q21. A laboratory reports that bacteria retain crystal violet during Gram staining. Which cell-wall feature most directly explains this?

A. A relatively thick peptidoglycan layerB. An outer membrane rich in lipopolysaccharideC. Absence of a cell wallD. Chitin-rich cell wallE. Large intracellular nucleus

View detailed explanation, examiner trap and viva

Correct answer: A. A relatively thick peptidoglycan layer

Why correct: Gram-positive envelopes retain the primary dye–iodine complex during decolorisation because of their thick peptidoglycan.

Why the other options are incorrect:

B. An outer membrane rich in lipopolysaccharide: This is a feature of many Gram-negative bacteria.

C. Absence of a cell wall: Wall-less organisms do not show this typical staining behaviour.

D. Chitin-rich cell wall: Chitin is a fungal cell-wall component.

E. Large intracellular nucleus: Bacteria are prokaryotes without a membrane-bound nucleus.

Exam pearl: Gram-positive = thick peptidoglycan; Gram-negative = outer membrane/LPS.

Examiner trap: Not every Gram-positive species responds clinically to the same antibiotic.

Viva extension — What does endotoxin refer to in Gram-negative bacteria? Answer: Lipid A component of lipopolysaccharide.

Question 22 of 40 • S aureus surgical infections

Q22. Three days after clean skin surgery, a patient develops a tender purulent incisional infection with clusters of Gram-positive cocci. What common causative organism should be considered?

A. Plasmodium falciparumB. Staphylococcus aureusC. Helicobacter pyloriD. Vibrio choleraeE. Aspergillus fumigatus

View detailed explanation, examiner trap and viva

Correct answer: B. Staphylococcus aureus

Why correct: S aureus is an important cause of postoperative purulent skin and soft-tissue infection.

Why the other options are incorrect:

A. Plasmodium falciparum: A protozoal blood parasite, not a typical purulent wound pathogen.

C. Helicobacter pylori: Primarily infects gastric mucosa.

D. Vibrio cholerae: Classically causes secretory diarrhoea.

E. Aspergillus fumigatus: A mould, not Gram-positive cocci in clusters.

Exam pearl: S aureus is a major surgical wound pathogen.

Examiner trap: Organism choice still depends on wound site, procedure and cultures.

Viva extension — What resistance phenotype changes empirical choices? Answer: MRSA, depending on local epidemiology and risk.

Question 23 of 40 • Prophylaxis timing

Q23. An elective colorectal procedure warrants antimicrobial prophylaxis. Which principle best describes the timing of intravenous prophylaxis?

A. Start only after the wound is closedB. Begin a full treatment course for every clean operationC. Establish appropriate drug levels in tissue by the time of incisionD. Wait for a positive postoperative cultureE. Give it only when pus develops

View detailed explanation, examiner trap and viva

Correct answer: C. Establish appropriate drug levels in tissue by the time of incision

Why correct: The purpose is to have adequate local antibacterial exposure at the moment operative contamination may occur.

Why the other options are incorrect:

A. Start only after the wound is closed: This misses the incision-time preventive window.

B. Begin a full treatment course for every clean operation: Prophylaxis does not mean extended therapeutic antibiotics.

D. Wait for a positive postoperative culture: That is no longer preincision prophylaxis.

E. Give it only when pus develops: That would address an established infection, not prevention.

Exam pearl: Prophylaxis should be appropriately timed before incision.

Examiner trap: The exact interval depends on the agent and protocol, especially prolonged infusions.

Viva extension — What else can necessitate intraoperative redosing? Answer: Prolonged operation or major blood loss according to drug half-life and protocol.

Question 24 of 40 • Redosing

Q24. A lengthy operation exceeds several half-lives of the selected prophylactic drug. What is the relevant rationale for considering an additional dose?

A. To treat an infection that has definitely occurredB. To convert prophylaxis into indefinite therapyC. To prevent any need for haemostasisD. To maintain effective tissue concentrations during the procedureE. To correct hypovolaemia

View detailed explanation, examiner trap and viva

Correct answer: D. To maintain effective tissue concentrations during the procedure

Why correct: Intraoperative redosing may be indicated when drug exposure falls during a prolonged case or substantial blood loss.

Why the other options are incorrect:

A. To treat an infection that has definitely occurred: Long operating time alone does not prove postoperative infection.

B. To convert prophylaxis into indefinite therapy: Routine prolonged therapy is not the goal.

C. To prevent any need for haemostasis: Antibiotics do not replace haemostasis.

E. To correct hypovolaemia: Fluids/blood and haemorrhage control address hypovolaemia.

Exam pearl: Redosing decisions are agent- and procedure-specific.

Examiner trap: Redosing is not the same as continuing antibiotics for days after closure.

Viva extension — Name one additional variable affecting prophylactic exposure. Answer: Major blood loss, body size or renal function depending on the agent.

Question 25 of 40 • Duration of prophylaxis

Q25. A patient has uncomplicated clean-contaminated surgery with a drain left in situ. Under CDC SSI-prevention recommendations, which statement about additional routine prophylactic doses after closure is correct?

A. Continue antibiotics until the drain is removedB. Convert prophylaxis to a two-week therapeutic courseC. Continue until wound staples are removedD. Use maximal-spectrum antibiotics indefinitelyE. Do not continue routine prophylactic dosing solely because a drain remains

View detailed explanation, examiner trap and viva

Correct answer: E. Do not continue routine prophylactic dosing solely because a drain remains

Why correct: CDC guidance recommends no further prophylactic doses after incision closure for clean and clean-contaminated operations, even with a drain.

Why the other options are incorrect:

A. Continue antibiotics until the drain is removed: Drain presence alone is not a sufficient indication under the cited recommendation.

B. Convert prophylaxis to a two-week therapeutic course: No established infection is present.

C. Continue until wound staples are removed: Staple removal does not determine prophylaxis duration.

D. Use maximal-spectrum antibiotics indefinitely: Unnecessary antibiotics promote harms and resistance.

Exam pearl: A drain is not itself justification for postoperative prophylactic continuation.

Examiner trap: Distinguish prophylaxis from treatment of a dirty or infected wound.

Viva extension — Where should clinicians check for a procedure-specific exception? Answer: Current local and speciality-specific guidelines.

Question 26 of 40 • Source control

Q26. A postoperative patient has a large rim-enhancing intra-abdominal collection and persistent fever despite appropriate antibiotics. Which intervention is usually the critical additional step?

A. Drainage or operative source control of the collectionB. Indefinite broad-spectrum escalation without reassessmentC. Routine vitamin supplementation onlyD. Simply increasing oral analgesiaE. Delaying all cultures and imaging indefinitely

View detailed explanation, examiner trap and viva

Correct answer: A. Drainage or operative source control of the collection

Why correct: An abscess may require procedural drainage or surgery to eliminate the focus; drugs alone may not achieve adequate control.

Why the other options are incorrect:

B. Indefinite broad-spectrum escalation without reassessment: Spectrum expansion does not empty a mature abscess.

C. Routine vitamin supplementation only: Does not address an infected collection.

D. Simply increasing oral analgesia: May reduce pain but does not control the infection source.

E. Delaying all cultures and imaging indefinitely: Hinders reassessment and targeted treatment.

Exam pearl: Drain the source when indicated; antibiotics are adjuncts.

Examiner trap: A culture positive for bacteria is not itself a procedural drainage indication absent context.

Viva extension — Name one other source-control action. Answer: Removal of infected devitalised tissue or control of a leak.

Question 27 of 40 • Culture sampling

Q27. A surgeon investigates a suspected deep prosthetic infection. Which specimen is generally most useful for identifying the causative organism?

A. One superficial skin swab aloneB. Multiple appropriately collected deep operative tissue samplesC. A photograph of the skin incisionD. A normal plain radiograph aloneE. A postoperative pain score

View detailed explanation, examiner trap and viva

Correct answer: B. Multiple appropriately collected deep operative tissue samples

Why correct: Deep samples obtained using sterile technique from relevant sites help distinguish true deep infection from superficial colonisation.

Why the other options are incorrect:

A. One superficial skin swab alone: Frequently reflects colonisation and may miss deep pathogens.

C. A photograph of the skin incision: Useful documentation but not microbiology.

D. A normal plain radiograph alone: Cannot identify the organism.

E. A postoperative pain score: Assesses symptoms but cannot provide pathogen identification.

Exam pearl: Multiple concordant deep specimens improve microbiological interpretation.

Examiner trap: Antibiotics before samples may reduce culture yield, but never delay emergency treatment of unstable patients.

Viva extension — What is a reason for a negative culture in genuine infection? Answer: Prior antimicrobial exposure or fastidious/low-burden organisms.

Question 28 of 40 • Surgical wound class

Q28. A planned bowel resection includes controlled entry into the intestinal lumen without gross spillage or preexisting infection. What operative wound class is most appropriate?

A. CleanB. ContaminatedC. Clean-contaminatedD. Dirty/infectedE. Organ-space SSI

View detailed explanation, examiner trap and viva

Correct answer: C. Clean-contaminated

Why correct: Controlled entry into a colonised viscus without gross contamination is traditionally classified clean-contaminated.

Why the other options are incorrect:

A. Clean: Clean wounds do not involve controlled bowel-lumen entry.

B. Contaminated: Usually involves gross spillage, acute nonpurulent inflammation or major sterile breach.

D. Dirty/infected: Established infection/perforation is not present.

E. Organ-space SSI: A postoperative infection definition, not a preoperative wound class.

Exam pearl: Operative wound class differs from SSI anatomical depth.

Examiner trap: A clean-contaminated operation does not necessarily develop an SSI.

Viva extension — What type of case may be classed dirty/infected? Answer: Perforated bowel with established peritonitis.

Question 29 of 40 • Time-dependent exposure

Q29. An MRCS question compares pharmacodynamic behaviour of cefazolin and gentamicin. Which parameter is particularly important for beta-lactam efficacy?

A. Only the highest peak concentrationB. Patient age independent of exposureC. Presence of an implanted drainD. Duration free drug concentration exceeds MICE. Duration of post-discharge bed rest

View detailed explanation, examiner trap and viva

Correct answer: D. Duration free drug concentration exceeds MIC

Why correct: Many beta-lactams exhibit time-dependent killing correlated with time above MIC.

Why the other options are incorrect:

A. Only the highest peak concentration: Concentration-dependent agents such as aminoglycosides have greater peak relevance.

B. Patient age independent of exposure: Patient factors matter, but not this antimicrobial PD index.

C. Presence of an implanted drain: A procedural factor, not the primary drug PD index.

E. Duration of post-discharge bed rest: Not an antibiotic activity determinant.

Exam pearl: fT>MIC is the classic beta-lactam PK/PD marker.

Examiner trap: Avoid inferring treatment duration from dosing interval alone.

Viva extension — What affects measured drug exposure? Answer: Renal function, dose, interval, distribution and pharmacokinetics.

Question 30 of 40 • Concentration-dependent exposure

Q30. Which antimicrobial class classically demonstrates concentration-dependent bactericidal activity with a significant post-antibiotic effect?

A. PenicillinsB. CephalosporinsC. ClindamycinD. VancomycinE. Aminoglycosides

View detailed explanation, examiner trap and viva

Correct answer: E. Aminoglycosides

Why correct: Aminoglycoside activity is related to high peak/MIC exposure, subject to regimen-specific dosing and toxicity limits.

Why the other options are incorrect:

A. Penicillins: Mainly time-dependent beta-lactam killing.

B. Cephalosporins: Also primarily time-dependent beta-lactam action.

C. Clindamycin: A 50S translation inhibitor not the characteristic class for this PD pattern.

D. Vancomycin: Activity relates to AUC/MIC rather than classic peak-driven aminoglycoside killing.

Exam pearl: Peak/MIC relevance distinguishes aminoglycosides from beta-lactams.

Examiner trap: Toxicity still limits dosing; high peaks are not automatically safe.

Viva extension — Which two toxicities are important? Answer: Nephrotoxicity and ototoxicity.

Question 31 of 40 • Loading dose

Q31. A critically ill adult requires an antibiotic loading dose to achieve the target plasma concentration rapidly. Which patient/drug variable principally determines the loading-dose calculation?

A. Volume of distributionB. Elimination clearance aloneC. Serum sodium concentration aloneD. Patient blood groupE. The number of previous operations

View detailed explanation, examiner trap and viva

Correct answer: A. Volume of distribution

Why correct: Loading dose is proportional to target concentration and volume of distribution, adjusted for bioavailability.

Why the other options are incorrect:

B. Elimination clearance alone: Mainly determines maintenance dose/rate.

C. Serum sodium concentration alone: Not the primary loading-dose variable.

D. Patient blood group: Not a PK dose determinant.

E. The number of previous operations: Not part of basic loading-dose calculation.

Exam pearl: Loading dose tracks distribution; maintenance tracks clearance.

Examiner trap: Renal failure commonly alters maintenance dosing more than the initial volume-based loading concept.

Viva extension — State a simplified IV loading-dose formula. Answer: Loading dose = target concentration multiplied by volume of distribution.

Question 32 of 40 • Maintenance dose

Q32. An antibiotic is cleared almost entirely by the kidneys. The patient develops acute kidney injury. Which parameter most directly needs reassessment for ongoing maintenance dosing?

A. Patient eye colourB. Drug clearanceC. The drug label fontD. The original wound length aloneE. Coagulation factor VIII level alone

View detailed explanation, examiner trap and viva

Correct answer: B. Drug clearance

Why correct: Reduced renal elimination may increase exposure; dose or interval and monitoring need review.

Why the other options are incorrect:

A. Patient eye colour: No relevance to routine antimicrobial clearance.

C. The drug label font: No pharmacokinetic relevance.

D. The original wound length alone: Does not quantify renal drug elimination.

E. Coagulation factor VIII level alone: Not a measure of antibiotic clearance.

Exam pearl: Renal function is crucial for maintenance exposure of renally cleared agents.

Examiner trap: Some drugs require both a loading dose and tailored maintenance despite AKI.

Viva extension — What other approach helps for narrow therapeutic index antibiotics? Answer: Therapeutic drug monitoring when indicated.

Question 33 of 40 • Gentamicin renal failure

Q33. A patient on gentamicin develops a marked fall in estimated kidney function. What is the safest general prescribing principle?

A. Automatically double every doseB. Assume normal renal eliminationC. Review dosing interval/exposure and monitor levels where indicatedD. Ignore other nephrotoxic drugsE. Continue unchanged indefinitely without review

View detailed explanation, examiner trap and viva

Correct answer: C. Review dosing interval/exposure and monitor levels where indicated

Why correct: Gentamicin is substantially renally eliminated and may accumulate with changing kidney function.

Why the other options are incorrect:

A. Automatically double every dose: May dangerously elevate exposure.

B. Assume normal renal elimination: Contradicts the renal deterioration.

D. Ignore other nephrotoxic drugs: Concomitant nephrotoxins affect risk.

E. Continue unchanged indefinitely without review: Creates avoidable toxicity risk.

Exam pearl: Gentamicin regimens require renal review and often drug levels.

Examiner trap: An eGFR estimate may be unreliable in rapidly changing acute kidney injury.

Viva extension — Name another aminoglycoside toxicity. Answer: Vestibular or auditory ototoxicity.

Question 34 of 40 • Anaphylaxis

Q34. Minutes after an antibiotic infusion, a patient develops wheeze, hypotension and rapidly spreading urticaria. What is first-line pharmacological treatment for suspected anaphylaxis?

A. Oral antihistamine aloneB. Oral corticosteroid as the first emergency drugC. Intravenous furosemideD. Intramuscular adrenalineE. Prophylactic warfarin

View detailed explanation, examiner trap and viva

Correct answer: D. Intramuscular adrenaline

Why correct: Adrenaline is the primary emergency drug for anaphylaxis, together with ABC assessment and resuscitation.

Why the other options are incorrect:

A. Oral antihistamine alone: May relieve itching but does not promptly reverse airway and circulatory compromise.

B. Oral corticosteroid as the first emergency drug: Not a replacement for immediate adrenaline.

C. Intravenous furosemide: May worsen haemodynamic compromise and does not treat anaphylaxis.

E. Prophylactic warfarin: An anticoagulant with no role in the acute allergic emergency.

Exam pearl: Anaphylaxis = prompt intramuscular adrenaline per current guideline.

Examiner trap: A rash is not required in every episode of anaphylaxis.

Viva extension — What other immediate actions are needed? Answer: Call for help, stop trigger, manage airway/oxygenation/circulation, follow local emergency protocol.

Question 35 of 40 • Local anaesthetic mechanism

Q35. A surgeon infiltrates lidocaine around a laceration for suturing. Which ion channel does the drug primarily block in nerves?

A. Voltage-gated calcium channel at the NMJB. Potassium leak channels onlyC. GABA-A receptor chloride channelD. Nicotinic acetylcholine receptors at muscle endplateE. Voltage-gated sodium channel

View detailed explanation, examiner trap and viva

Correct answer: E. Voltage-gated sodium channel

Why correct: Local anaesthetics inhibit action-potential propagation by blocking voltage-gated Na+ channels.

Why the other options are incorrect:

A. Voltage-gated calcium channel at the NMJ: Not the principal lidocaine conduction-block mechanism.

B. Potassium leak channels only: Not the central anaesthetic target.

C. GABA-A receptor chloride channel: The target of some sedative/hypnotic pharmacology.

D. Nicotinic acetylcholine receptors at muscle endplate: Blocked by nondepolarising neuromuscular blockers.

Exam pearl: Local anaesthetics block voltage-gated Na+ channels.

Examiner trap: Local infiltration anaesthesia is not neuromuscular blockade.

Viva extension — Why can inflamed tissue be hard to anaesthetise? Answer: Acidic tissue can reduce the membrane-permeable uncharged fraction of weak-base local anaesthetics.

Question 36 of 40 • Local anaesthetic toxicity

Q36. During a regional block, a patient develops seizures followed by ventricular arrhythmias after bupivacaine exposure. Which specific rescue adjunct is considered in addition to resuscitation?

A. Intravenous lipid emulsion under a LAST protocolB. Naloxone as definitive treatmentC. Flumazenil as definitive treatmentD. Vitamin KE. Protamine

View detailed explanation, examiner trap and viva

Correct answer: A. Intravenous lipid emulsion under a LAST protocol

Why correct: Local anaesthetic systemic toxicity may require appropriate lipid-emulsion therapy along with airway, seizure and cardiovascular management.

Why the other options are incorrect:

B. Naloxone as definitive treatment: Reverses opioid-mediated respiratory effects, not sodium-channel toxicity from bupivacaine.

C. Flumazenil as definitive treatment: A benzodiazepine antagonist, not a local-anaesthetic reversal agent.

D. Vitamin K: Reverses warfarin effects, not bupivacaine toxicity.

E. Protamine: Reverses heparin, not local-anaesthetic cardiac toxicity.

Exam pearl: Seizures plus arrhythmias after a block suggest LAST.

Examiner trap: Stop injection immediately and follow emergency lipid-rescue guidance; dosing is protocol-specific.

Viva extension — What is a key toxicity association of bupivacaine? Answer: Potentially severe cardiotoxicity with systemic exposure.

Question 37 of 40 • Opioid reversal

Q37. A postoperative patient receiving morphine is difficult to rouse with marked respiratory depression and pinpoint pupils. Which specific antagonist may reverse opioid effects?

A. FlumazenilB. NaloxoneC. Vitamin KD. NeostigmineE. Adrenaline alone

View detailed explanation, examiner trap and viva

Correct answer: B. Naloxone

Why correct: Naloxone competitively antagonises opioid receptors and can reverse opioid-induced respiratory depression.

Why the other options are incorrect:

A. Flumazenil: Reverses benzodiazepines, not opioid receptor agonism.

C. Vitamin K: Counters warfarin-mediated vitamin K antagonism.

D. Neostigmine: Reverses selected neuromuscular blocking agents, not morphine toxicity.

E. Adrenaline alone: Not the specific opioid receptor antagonist.

Exam pearl: Naloxone reverses opioids; monitor for re-sedation as durations may differ.

Examiner trap: Airway and ventilation take priority over waiting for an antidote.

Viva extension — Why may repeated naloxone be needed? Answer: Some opioids persist longer than naloxone.

Question 38 of 40 • NSAIDs

Q38. A dehydrated older postoperative patient receiving an NSAID develops renal impairment. Which pharmacological action contributes to risk of reduced renal perfusion?

A. Direct beta-lactam PBP inhibitionB. Opioid mu-receptor agonismC. Cyclo-oxygenase inhibition with reduced vasodilatory prostaglandinsD. Antithrombin potentiationE. D-Ala-D-Ala binding

View detailed explanation, examiner trap and viva

Correct answer: C. Cyclo-oxygenase inhibition with reduced vasodilatory prostaglandins

Why correct: NSAIDs reduce renal prostaglandin synthesis, potentially reducing afferent arteriolar support in volume-depleted states.

Why the other options are incorrect:

A. Direct beta-lactam PBP inhibition: An antibiotic action, not NSAID renal pharmacology.

B. Opioid mu-receptor agonism: Action of morphine-class analgesics.

D. Antithrombin potentiation: Unfractionated heparin mechanism.

E. D-Ala-D-Ala binding: Vancomycin mechanism.

Exam pearl: NSAIDs can precipitate AKI in susceptible hypovolaemic patients.

Examiner trap: Normal baseline creatinine does not remove acute volume-depletion risk.

Viva extension — Name another common NSAID risk. Answer: Gastrointestinal bleeding/ulceration.

Question 39 of 40 • Heparin

Q39. Which endogenous anticoagulant protein has its activity accelerated by unfractionated heparin?

A. Vitamin K epoxide reductaseB. Cyclo-oxygenase-1C. Plasminogen onlyD. AntithrombinE. Factor VIII synthesis directly

View detailed explanation, examiner trap and viva

Correct answer: D. Antithrombin

Why correct: Heparin enhances antithrombin inhibition of thrombin and factor Xa among other serine proteases.

Why the other options are incorrect:

A. Vitamin K epoxide reductase: Warfarin inhibits this enzyme.

B. Cyclo-oxygenase-1: Aspirin irreversibly inhibits platelet COX-1.

C. Plasminogen only: Thrombolytics act through plasminogen activation, not standard heparin action.

E. Factor VIII synthesis directly: Heparin does not principally suppress factor VIII transcription.

Exam pearl: UFH works through antithrombin.

Examiner trap: Heparin is not a fibrinolytic drug.

Viva extension — Which agent may reverse unfractionated heparin? Answer: Protamine, given under an appropriate protocol.

Question 40 of 40 • Warfarin

Q40. A patient receiving long-term warfarin requires INR monitoring. Which enzyme is inhibited by warfarin?

A. AntithrombinB. Platelet cyclo-oxygenaseC. Thrombin catalytic site directlyD. Bacterial DNA gyraseE. Vitamin K epoxide reductase

View detailed explanation, examiner trap and viva

Correct answer: E. Vitamin K epoxide reductase

Why correct: Warfarin interferes with reduced vitamin K recycling and decreases functional vitamin K-dependent clotting factors.

Why the other options are incorrect:

A. Antithrombin: Heparin enhances antithrombin; warfarin does not.

B. Platelet cyclo-oxygenase: Aspirin mechanism.

C. Thrombin catalytic site directly: Direct thrombin inhibitors act there.

D. Bacterial DNA gyrase: Fluoroquinolone target, not an anticoagulant enzyme.

Exam pearl: Warfarin affects factors II, VII, IX and X, and proteins C/S.

Examiner trap: A newly started warfarin prescription does not produce immediate full anticoagulation.

Viva extension — What laboratory marker is ordinarily monitored? Answer: INR, alongside clinical bleeding and interaction assessment.

Frequently asked questions

Are these actual MRCS questions?

No. All 40 SBAs are original educational questions written to target published surgical pharmacology and microbiology concepts.

How are prophylaxis and antibiotic treatment different?

Prophylaxis seeks to prevent infection at a planned procedural exposure; treatment addresses an established or clinically suspected infection and may require source control.

Does every positive surgical-wound swab require antibiotics?

No. Interpret the specimen quality, colonisation, clinical signs and the need for source control.

Why do aminoglycosides require careful monitoring?

They can cause renal and auditory/vestibular toxicity, particularly with inappropriate exposure or declining renal function.

Can I come back to the quiz later?

Yes. The page attempts to save progress locally on the same browser and device. Progress may be lost if storage is cleared.

What is the main antibiotic stewardship principle?

Use antibiotics only when clinically indicated, review culture results and response, and choose the narrowest effective regimen of appropriate duration.

References and related MRCS articles

Reading references support broad concepts; do not extrapolate fixed antibiotic choices or doses to patients without current protocols, pathogen susceptibility and an appropriate clinical assessment.

1. Intercollegiate MRCS candidate guidance — Published MRCS examination structure and subject guidance.
2. NICE NG125: Surgical site infection prevention and treatment — Antimicrobial prophylaxis, treatment and wound infection guidance.
3. NICE NG15: Antimicrobial stewardship — Appropriate antibiotic use and review systems.
4. WHO AWaRe classification 2025 — Access, Watch and Reserve stewardship grouping.
5. CDC 2017 SSI prevention guideline — Antibiotic exposure at incision and routine post-closure prophylaxis.
6. NCBI Bookshelf: Beta-lactam antibiotics — Mechanisms and antibacterial pharmacology.
7. NCBI Bookshelf: Cephalosporins — PBPs and selected resistance principles.

Published MRCS Academy lessons

Article 01
Start MRCS HereArticle 02
Complete SyllabusArticle 03
Books & ResourcesArticle 04
12-Week Study PlanArticle 05
SBA TechniqueArticle 06
Preparation MistakesArticle 07
Surgical Anatomy OverviewArticle 08
Upper Limb AnatomyArticle 09
Inguinal & Abdominal WallArticle 10
Head & Neck AnatomyArticle 11
Cardiovascular & Respiratory PhysiologyArticle 12
Renal & Acid–Base PhysiologyArticle 13
GI, Endocrine & NeurophysiologyArticle 14
Lower Limb AnatomyArticle 15
Thoracic, Pelvic & Visceral AnatomyArticle 16
Surgical Pathology & Wound Healing

Previous lesson: Article 16 — Surgical Pathology, Inflammation and Wound Healing

Next lesson: Article 18 — Perioperative Care, Anaesthesia and Surgical Complications.

Editorial date: 16 October 2026 • FreeMedSite independent teaching resources